Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Rheum Dis ; 69(1): 291-6, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19204014

ABSTRACT

BACKGROUND: Acquired resistance to glucocorticoids constitutes a major clinical challenge, often overlooked in the search for improved alternatives to classic steroids. We sought to unravel how two glucocorticoid receptor-activating compounds, dexamethasone and Compound A, influence glucocorticoid receptor levels and how this can be correlated to their gene regulatory potential. METHODS: Compound A and dexamethasone were applied in a short-term and long-term treatment protocol. By quantitative PCR analysis in fibroblast-like synoviocytes (FLS) the gene regulatory potential of both compounds in the two experimental conditions was analysed. A parallel Western blot assay revealed the glucocorticoid receptor protein levels in both conditions (ex vivo). In addition, this study examined the effect of systemic administration of dexamethasone and Compound A, in concentrations effective to inhibit collagen-induced arthritis, in DBA/1 mice on glucocorticoid receptor levels (in vivo). RESULTS: Compound A does not induce a homologous downregulation of glucocorticoid receptor in vivo and ex vivo, thereby retaining its anti-inflammatory effects after prolonged treatment in FLS. This is in sharp contrast to dexamethasone, showing a direct link between prolonged dexamethasone treatment, decreasing glucocorticoid receptor levels, and the abolishment of inflammatory gene repression in FLS. It was also observed that the acquired low receptor levels after prolonged dexamethasone treatment are still sufficient to sustain the transactivation of endogenous glucocorticoid-responsive element-driven genes in FLS, a mechanism partly held accountable for the metabolic side-effects. CONCLUSION: Compound A is less likely to evoke therapy resistance, as it does not lead to homologous glucocorticoid receptor downregulation, which is in contrast to classic glucocorticoids.


Subject(s)
Acetates/therapeutic use , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Arthritis, Experimental/prevention & control , Arthritis, Rheumatoid/prevention & control , Ethylamines/therapeutic use , Receptors, Glucocorticoid/agonists , Acetates/pharmacology , Animals , Anti-Inflammatory Agents, Non-Steroidal/pharmacology , Arthritis, Experimental/metabolism , Arthritis, Rheumatoid/metabolism , Cells, Cultured , Dexamethasone/pharmacology , Dexamethasone/therapeutic use , Down-Regulation/drug effects , Drug Evaluation, Preclinical/methods , Drug Resistance , Ethylamines/pharmacology , Glucocorticoids/pharmacology , Glucocorticoids/therapeutic use , Inflammation Mediators/metabolism , Ligands , Male , Mice , Mice, Inbred DBA , Receptors, Glucocorticoid/drug effects , Receptors, Glucocorticoid/physiology , Tyramine/analogs & derivatives
2.
Ann Rheum Dis ; 68(8): 1360-5, 2009 Aug.
Article in English | MEDLINE | ID: mdl-18772190

ABSTRACT

OBJECTIVES: Improved DNA sequencer-aided fluorophore-assisted carbohydrate electrophoresis (DSA-FACE) technology was used to monitor the changes in the galactosylation status of serum immunoglobulins during the immune response and therapy of autoimmune arthritis. METHODS: Collagen-induced arthritis (CIA) was induced in susceptible DBA/1 mice and the undergalactosylation status (UGS) of serum immunoglobulins was determined using the improved DSA-FACE technology. Prophylactic intravenous tolerisation with type II collagen as well as semitherapeutic treatment with dexamethasone (DEX) were performed and UGS was analysed. Next, the serum immunoglobulin glycosylation profiles of patients with rheumatoid arthritis (RA) and spondyloarthropathy (SpA) were studied and changes in the UGS scores during anti-tumour necrosis factor (TNF)alpha therapy followed. RESULTS: In the longitudinal CIA study, the undergalactosylation state of immunoglobulins was found to be significantly correlated with the clinical arthritis scores. Upon collagen-specific tolerisation as well as glucocorticoid semitherapeutic treatment, improvement of the clinical arthritis scores correlated with decreased levels of UGS. It was also demonstrated that withdrawal of DEX was associated with an increased UGS score. Interestingly, reversibility in the UGS was also shown during treatment of patients with RA and SpA with anti-TNFalpha. CONCLUSIONS: These findings demonstrate that the UGS of serum immunoglobulins changes during the disease course of CIA and that this UGS is inhibited by antigen-specific and antigen-independent treatment procedures. The observation that Ig galactosylation is a reversible process is also documented during treatment of patients with RA and SpA with anti-TNFalpha.


Subject(s)
Arthritis, Experimental/immunology , Immunoglobulins/blood , Polysaccharides/blood , Adult , Aged , Animals , Anti-Inflammatory Agents/therapeutic use , Antirheumatic Agents/therapeutic use , Arthritis, Experimental/drug therapy , Arthritis, Experimental/prevention & control , Arthritis, Rheumatoid/drug therapy , Arthritis, Rheumatoid/immunology , Dexamethasone/therapeutic use , Disease Progression , Humans , Immune Tolerance , Immunoglobulin G/blood , Male , Mice , Mice, Inbred DBA , Middle Aged , Spondylarthropathies/drug therapy , Spondylarthropathies/immunology , Tumor Necrosis Factor-alpha/antagonists & inhibitors
3.
Rheumatology (Oxford) ; 46(4): 565-71, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17307755

ABSTRACT

The importance of T cell participation in the aetiology and pathogenesis of rheumatoid arthritis (RA) is now widely appreciated. The disease is mediated by activated pro-inflammatory, self-reactive T helper cells, instigating the chronic autoimmune response characteristic of rheumatoid inflammation. Natural killer T (NKT) cells are a distinctive population of T cells thought to protect self-tissues from damaging inflammatory immune responses, and are often recognized as a regulatory T cell subtype, regulating the magnitude or class of the immune response. Recently, a number of studies have provided insight concerning the role of NKT cells in different models of autoimmune joint inflammation, suggesting the involvement of this specialized T cell subset in controlling initiation and perpetuation of arthritic disease. The aim of this review is to provide rheumatologists with an introduction of the principal features of NKT cells, to give an overview of the data obtained in animal models of arthritis and to discuss the hypothesized mechanisms. Finally, we will speculate on future prospects with regard to NKT cell-targeted treatment of arthritic disease by use of glycolipids.


Subject(s)
Arthritis, Rheumatoid/immunology , Autoimmune Diseases/immunology , Killer Cells, Natural/immunology , Animals , Arthritis, Experimental/immunology , Autoimmunity , Disease Models, Animal , Humans , Mice
4.
J Immunol ; 166(7): 4302-11, 2001 Apr 01.
Article in English | MEDLINE | ID: mdl-11254682

ABSTRACT

Murine NK cells express inhibitory receptors belonging to the Ly49 and CD94/NKG2 family. Ly49E and CD94 are the only NK cell receptor transcripts detectable in fetal NK cells. Still unproved is the surface expression of Ly49E on NK cells. Here we generated two novel mAbs, a mAb recognizing Ly49E with cross-reactivity to Ly49C, and a mAb against NKG2A/C/E. Ly49E was immunoprecipitated as a disulfide-linked homodimer with 46-kDa subunits. Removal of N-linked carbohydrates revealed a 31-kDa protein backbone. NKG2A was immunoprecipitated as a 38-kDa protein. Although the frequency of fetal NK cells expressing Ly49E was higher than 25%, it decreased drastically from 2 wk after birth. Phenotypic analysis showed that approximately 90% of fetal NK cells and approximately 50% of adult NK cells express high levels of CD94/NKG2. The remaining 50% of adult NK cells expressed low surface levels of CD94/NKG2. Expression of Ly49E and CD94/NKG2 was not restricted to NK cells, but was also observed on NK T and memory T cells. Functional analysis showed that sorted Ly49E(+) and CD94/NKG2(+) fetal NK cells could discriminate between MHC class I-positive and MHC class I-negative tumor cells. We also demonstrated that Ly49E becomes phosphorylated following pervanadate stimulation of fetal NK cells. The expression levels of Ly49E and CD94/NKG2 were similar in wild-type compared with beta(2)-microglobulin(-/-) mice. In conclusion, generation of mAbs against Ly49E and NKG2 extended the phenotypic and functional characterization of NK cells.


Subject(s)
Aging/immunology , Antigens, CD/biosynthesis , Antigens, Ly , Fetus/immunology , Killer Cells, Natural/metabolism , Lectins, C-Type , Membrane Glycoproteins/biosynthesis , Receptors, Immunologic/biosynthesis , Animals , Antibodies, Monoclonal/biosynthesis , Antibodies, Monoclonal/metabolism , Cell Differentiation/immunology , Cytotoxicity Tests, Immunologic , Fetus/metabolism , Immunologic Memory , Killer Cells, Natural/cytology , Killer Cells, Natural/immunology , Membrane Glycoproteins/chemistry , Membrane Glycoproteins/immunology , Membrane Glycoproteins/physiology , Mice , Mice, Inbred C57BL , Mice, Mutant Strains , NK Cell Lectin-Like Receptor Subfamily A , NK Cell Lectin-Like Receptor Subfamily C , NK Cell Lectin-Like Receptor Subfamily D , Phosphorylation , Rats , Rats, Inbred F344 , Receptors, Immunologic/chemistry , Receptors, Immunologic/immunology , Receptors, Immunologic/physiology , Receptors, KIR , Receptors, NK Cell Lectin-Like , Receptors, Natural Killer Cell , Spleen/cytology , T-Lymphocyte Subsets/immunology , T-Lymphocyte Subsets/metabolism , Thymus Gland/cytology , Tumor Cells, Cultured , Tyrosine/metabolism , beta 2-Microglobulin/deficiency , beta 2-Microglobulin/genetics
5.
J Immunol ; 165(2): 645-53, 2000 Jul 15.
Article in English | MEDLINE | ID: mdl-10878336

ABSTRACT

Langerhans cells (LCs) are immature dendritic cells (DCs) present in the skin epithelium. Upon Ag exposure, they migrate to the draining lymph nodes where they mature into potent stimulators of naive T cells. The aim of this study was to investigate the influence of T cells on LC migration and maturation. Therefore, the in vivo migration and maturation of LCs after sensitization with the hapten FITC was compared between C57BL/6 or BALB/c mice used as positive controls, and recombination activating gene (RAG) 1 knockout (-/-) mice or SCID mice used as T cell-deficient mice. Phenotypically, there was no difference between migrated LCs from RAG1-/- or SCID mice vs normal C57BL/6 or BALB/c mice: both populations of FITC+ cells had a dendritic morphology and a mature phenotype as they expressed high levels of MHC class II molecules and costimulatory molecules CD80, CD86, and CD54. Sorted migrated LCs of RAG1-/- or SCID mice were efficient stimulators of allogeneic T cells and Ag-specific CD4+ T cells. The same results were found if migrated LCs were fixed instead of irradiated, excluding the possibility that LCs derived from RAG1-/- or SCID mice would mature in the presence of T cells during the stimulation tests. Importantly, fixed migrated LCs of RAG1-/- mice were also efficient stimulators of cytotoxic CD8+ T cells. These data suggest that T cells are not required for full maturation of LCs.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Langerhans Cells/cytology , Langerhans Cells/immunology , Lymphocyte Activation , Lymphopenia/immunology , T-Lymphocytes, Cytotoxic/immunology , T-Lymphocytes/immunology , Animals , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Movement/genetics , Cell Movement/immunology , Fluorescein-5-isothiocyanate/administration & dosage , Haptens/administration & dosage , Haptens/immunology , Homeodomain Proteins/genetics , Immunization , Immunophenotyping , Lymphocyte Activation/genetics , Lymphopenia/genetics , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Knockout , Mice, SCID , Organ Culture Techniques , Skin/cytology , Skin/immunology , T-Lymphocytes/pathology , Transposases/genetics
6.
J Leukoc Biol ; 66(4): 625-33, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10534119

ABSTRACT

Natural killer (NK) cell phenotype and activity was studied by analyzing uncultured and short-time-cultured murine NK cells from fetal day 17 spleen and thymus. In contrast to NK cells from adult mice, freshly sorted fetal NK cells did not contain NK receptor transcripts for Ly-49A, B, C/I, D, F, G2, or H. The only NK receptor transcripts that could be detected were Ly-49E and CD94. It is important that Ly-49E was present at a 10- to 30-fold higher level compared with uncultured NK cells from adult mice. After short-time interleukin-2 culture, the level of Ly-49E mRNA was comparable between fetal and adult NK cells. Functionally, fetal NK cells only killed MHC class I-negative tumor cells when activating NK receptors were cross-linked with antibody. We show that fetal NK cells are mature but are different from NK cells in adult mice regarding their NK cell receptor repertoire and function.


Subject(s)
Antigens, Ly , Killer Cells, Natural/immunology , Membrane Glycoproteins/immunology , Receptors, Immunologic/immunology , Animals , Carrier Proteins/genetics , Cells, Cultured , Cytotoxicity, Immunologic , Female , Fetus/immunology , Gene Expression , Immunophenotyping , Interleukin-2 , Killer Cells, Natural/cytology , Lectins, C-Type , Male , Membrane Glycoproteins/genetics , Membrane Proteins/genetics , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Receptors, Immunologic/genetics , Receptors, NK Cell Lectin-Like , Recombinant Proteins , Spleen/cytology , Spleen/immunology , Thymus Gland/cytology , Thymus Gland/immunology
7.
J Immunol ; 158(10): 4634-41, 1997 May 15.
Article in English | MEDLINE | ID: mdl-9144475

ABSTRACT

In contrast to thymic differentiation of TCR alphabeta cells, differentiation stages of TCR gammadelta cells are largely unknown. This report shows that CD1, a known marker of immature TCR alphabeta thymocytes, was expressed on some postnatal TCR gammadelta thymocytes. Only CD1+ TCR gammadelta thymocytes expressed recombination-activating gene-1 mRNA, and they were shown to differentiate into CD1- TCR gammadelta thymocytes. Functionally, sorted CD1- TCR gammadelta thymocytes proliferated in the presence of immobilized anti-CD3 Ab plus exogenous rIL-2 or rIL-15. Interestingly, in contrast to CD1- TCR alphabeta cells, CD1- TCR gammadelta thymocytes also proliferated extensively when cultured with exogenous rIL-2 or rIL-15 alone. FACS analysis as well as reverse transcription-PCR analysis showed that only CD1- TCR gammadelta thymocytes expressed IL-2Rbeta protein and mRNA. The differential expression of maturation markers, such as CD27, CD45RO, and CD45RA, as a function of expression of CD1 was similar in TCR gammadelta and TCR alphabeta thymocytes. An important exception is the expression of CD4 and CD8. Whereas TCR alphabeta thymocytes are mainly CD4-CD8 double positive at the immature CD1+ stage and CD4 or CD8 single positive at the mature CD1- stage, CD1(bright) TCR gammadelta thymocytes all expressed CD4, but only some of them expressed CD8. Some CD1- TCR gammadelta thymocytes also expressed CD8, but were negative for CD4. Collectively, our data clearly show that CD1 is a useful marker to distinguish immature human TCR gammadelta thymocytes from functional mature gammadelta cells based on recombination-activating gene-1 expression, in vitro differentiation, and phenotypic and functional characteristics.


Subject(s)
Homeodomain Proteins , Receptors, Antigen, T-Cell, gamma-delta/metabolism , T-Lymphocyte Subsets/cytology , Thymus Gland/cytology , Antigens, CD1/metabolism , CD4 Antigens/analysis , CD8 Antigens/analysis , Cell Differentiation , Child , Child, Preschool , Flow Cytometry , Humans , Immunophenotyping , Infant , Organ Culture Techniques , Proteins/metabolism , Receptors, Antigen, T-Cell, alpha-beta/metabolism , Receptors, Interleukin-15 , Receptors, Interleukin-2/metabolism , T-Lymphocyte Subsets/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...